Buyers on the hunt for an upmarket three-row SUV aren't short on options, and that's partly why the Land Rover Discovery isn't a commercial hit in the same way as its Land Rover stablemates. Both the ...
AbCellera's AI-driven drug discovery model hasn't translated into meaningful growth; partnerships and clinical trial progress have stagnated despite recent stock price gains. Quarterly losses are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results